Therapeutic Asset Ratings
4,361 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Eloxatin
DNA Repair Disease
National Cancer Institute (NCI)
P3
B
(60)
Eloxatin
Lynch Syndrome
National Cancer Institute (NCI)
P3
B
(60)
Entinostat
Breast Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(60)
Epirubicin
Breast Carcinoma In Situ
National Cancer Institute (NCI)
P3
B
(60)
Epirubicin
Non-Cutaneous Melanoma
National Cancer Institute (NCI)
P3
B
(60)
ERIBULIN MONOMETHANESULFONATE
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)
P3
B
(60)
ETOPOSIDE
T-Cell Childhood Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
ETOPOSIDE
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P3
B
(60)
Evomela
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P3
B
(60)
EXEMESTANE
Breast Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(60)
EXEMESTANE
Multicentric Breast Carcinoma
National Cancer Institute (NCI)
P3
B
(60)
EXEMESTANE
Synchronous Bilateral Breast Carcinoma
National Cancer Institute (NCI)
P3
B
(60)
FILGRASTIM
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
FILGRASTIM
Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance
National Cancer Institute (NCI)
P3
B
(60)
FILGRASTIM
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P3
B
(60)
Fludarabine
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P3
B
(60)
FLUOROURACILUM
DNA Repair Disease
National Cancer Institute (NCI)
P3
B
(60)
FLUOROURACILUM
Lynch Syndrome
National Cancer Institute (NCI)
P3
B
(60)
Ibrutinib
Anemia
National Cancer Institute (NCI)
P3
B
(60)
Ibrutinib
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P3
B
(60)
Ifosfamide
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
B
(60)
Ifosfamide
T-Cell Childhood Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
Ifosfamide
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
B
(60)
Inno-206
T-Cell Childhood Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
Inno-206
Ovarian Serous Tumor
National Cancer Institute (NCI)
P3
B
(60)
Showing 676 to 700 of 4,361 assets
Previous
Page 28 of 175
Next